How to inject GLP-1 — technique, sites, and what to expect. - Reddit

What does subcutaneous injection mean for GLP-1 medications?

Compounded GLP-1 medications — including compounded semaglutide and tirzepatide — are administered subcutaneously. Subcutaneous means “under the skin,” specifically into the layer of fatty tissue (hypodermis) that sits between the skin and the muscle beneath.

This is different from intramuscular injection (into muscle) or intravenous injection (into a vein). Subcutaneous injection is chosen because GLP-1 receptor agonists absorb well from fatty tissue, the process is low-pain with a fine-gauge needle, and patients can self-administer reliably once trained.

The needle used is typically short (4–6 mm) and fine (29–31 gauge) — meaningfully smaller than what many people picture when they hear the word “injection.”

Where do you inject a GLP-1 medication?

Three sites work well for subcutaneous GLP-1 injection. All have adequate subcutaneous fat depth in most patients and are accessible for self-injection:

• Abdomen: The area between the lower ribcage and the waistband, at least 2 inches (5 cm) away from the navel. The abdomen is the most commonly used site because it is easy to access and tends to have consistent subcutaneous fat depth. Avoid the navel itself and any scar tissue.
• Outer thigh: The front and outer portion of the thigh, roughly from mid-thigh to about four inches above the knee. Avoid the inner thigh and the knee area. This site works well if you prefer a location you can see clearly.
• Upper arm: The back or outer upper arm, between the shoulder and elbow. This site can be harder to self-inject without assistance. If used, a pinch-and-inject technique helps ensure subcutaneous placement.

Rotate between sites and within sites — moving a few centimeters from the previous injection point each week. This reduces the risk of lipohypertrophy, a condition where repeated injection at the same spot causes hard, fatty nodules that can impair medication absorption.

How do you inject a GLP-1 medication step by step?

Your clinician and pharmacy will provide formulation-specific instructions. General subcutaneous injection technique for GLP-1 medications follows established best practices:

1. Prepare the medication: Remove from the refrigerator 15–30 minutes before injecting. Cold medication increases injection discomfort. Visually inspect the solution — it should be clear to slightly yellow and free of particles. Do not use if discolored or cloudy unless your pharmacy instructions specify otherwise.
2. Wash hands: Thorough soap-and-water handwashing before handling the injection equipment is non-negotiable.
3. Clean the site: Wipe the chosen injection site with an alcohol swab and allow it to air-dry completely before injecting. Injecting into wet skin stings more and can introduce alcohol into the tissue.
4. Pinch or relax the site: For thin subcutaneous fat layers (lean patients, thigh or arm sites), pinching the skin creates a lifted tissue pocket that helps avoid hitting muscle. For ample abdominal tissue, a gentle pinch is optional.
5. Insert the needle: With a short needle (4–5 mm), inject at 90 degrees to the skin surface. With a longer needle, a 45-degree angle reduces the risk of intramuscular placement in leaner tissue areas.
6. Inject slowly and steadily: Press the plunger at a steady, moderate pace. Rapid injection increases discomfort. For pen devices, hold after the dose is delivered per the manufacturer instruction (usually 5–10 seconds).
7. Withdraw and dispose: Withdraw the needle at the same angle used for insertion. Apply gentle pressure with a clean cotton ball if needed — do not rub, which can disperse medication from the site. Dispose of the used needle in a puncture-resistant sharps container immediately.

How should you store and handle a GLP-1 medication?

Compounded GLP-1 formulations are temperature-sensitive. Standard storage guidance for most compounded semaglutide and tirzepatide preparations:

• Refrigerate: Store at 2–8°C (36–46°F). Do not freeze. Freezing can damage the peptide structure and render the medication ineffective.
• Protect from light: Keep in the original packaging or a dark location when not in use.
• Respect expiration: Compounded medications have beyond-use dates set by the pharmacy. Never use medication past its labeled date.

Your pharmacy’s instructions for your specific formulation supersede general guidance. Some compounded preparations may have different requirements based on excipients or formulation method.

What your clinician should cover before your first injection

A responsible GLP-1 prescribing clinician will ensure you are prepared before your first injection. This typically includes:

• Dose and frequency specific to your formulation and titration schedule
• Which injection sites are appropriate for your body composition
• How to handle the specific syringe, vial, or pen device provided by your pharmacy
• How to identify and report adverse reactions (nausea, injection-site reactions, signs of infection)
• Sharps disposal requirements in your jurisdiction

If you received a prescription without a clinician walkthrough, contact them before injecting. The technique itself is simple — but the first injection is the right time to ask every question you have.

Frequently asked questions